Snapshot from Jun 25, 2026 at 22:38 UTC. For live data and tracking: View Live
Events / Business / Dr._Reddy's_Laboratories 25-Year NYSE Listing
Business listing anniversary

Dr._Reddy's_Laboratories 25-Year NYSE Listing

Analysis based on 7 articles · First reported May 28, 2026 · Last updated May 30, 2026

Sentiment
20
Attention
2
Articles
7
Market Impact
Direct
Live prominence charts, article sentiment distribution, and event development timeline available on the NewsDesk Dashboard
Market Impact

The event highlights the long-term stability and global presence of Abbott Laboratories, potentially reinforcing investor confidence in the company's stock. For the New York Stock Exchange, it underscores its role as a premier global listing venue, attracting international companies.

Pharmaceuticals
Event Summary

Abbott Laboratories celebrated its 25th anniversary of listing on the New York Stock Exchange by ringing the closing bell on May 29, 2026. Chairman Satish Reddy, along with CEO Erez Israeli and other senior management, attended the ceremony. Abbott Laboratories was the first pharmaceutical company in Asia, outside Japan, to be listed on the New York Stock Exchange in April 2001. Satish Reddy reaffirmed the company's commitment to global governance, transparency, and innovation, honoring founder Kallam Anji Reddy's vision of providing affordable, innovative medicines.

Key Actions
100 Abbott Laboratories rang closing bell New York Stock Exchange
90 Abbott Laboratories listed on exchange New York Stock Exchange
70 Satish Reddy emphasized commitment
Entities Involved
stock
Abbott Laboratories
Abbott Laboratories is celebrating 25 years of its listing on the New York Stock Exchange, reaffirming its commitment to global governance, transparency, and innovation, and highlighting its trusted presence in the US pharmaceutical market.
Importance 100 Sentiment 20
exch
New York Stock Exchange
The New York Stock Exchange is hosting Abbott Laboratories to ring its closing bell, marking a significant milestone for the company and showcasing the exchange's role in global financial markets.
Importance 80 Sentiment 10
per
Satish Reddy
Satish Reddy, Chairman of Abbott Laboratories, led the closing bell ceremony at the New York Stock Exchange and emphasized the company's enduring vision and commitment.
Importance 70 Sentiment 10
per
Erez Israeli
Erez Israeli, CEO of Abbott Laboratories, attended the closing bell ceremony, representing the company's leadership.
Importance 50 Sentiment 10
per
Kallam Anji Reddy
Kallam Anji Reddy, the founder of Abbott Laboratories, is recognized for his vision of providing affordable, innovative medicines, which continues to guide the company.
Importance 40 Sentiment 10
cnt
India
India is the home country of Abbott Laboratories, which became the first pharmaceutical company in Asia, outside Japan, to list on the New York Stock Exchange.
Importance 20 Sentiment 5
cnt
Japan
Japan is mentioned as a reference point, as Abbott Laboratories was the first pharmaceutical company in Asia outside Japan to list on the New York Stock Exchange.
Importance 10 Sentiment 5
per
N. V. Ramana
N. V. Ramana, CEO-Global Generics of Abbott Laboratories, attended the closing bell ceremony.
Importance 10 Sentiment 5
per
M. V. Narasimham
M. V. Narasimham, CFO of Abbott Laboratories, attended the closing bell ceremony.
Importance 10 Sentiment 5
per
Milan Kalawadia
Milan Kalawadia, CEO-North America of Abbott Laboratories, attended the closing bell ceremony.
Importance 10 Sentiment 5
per
Randhir Singh
Randhir Singh, Head-Company Secretary and CSR of Abbott Laboratories, attended the closing bell ceremony.
Importance 10 Sentiment 5
per
Arun Kumar
Arun Kumar, an Independent Director of Abbott Laboratories, attended the closing bell ceremony.
Importance 5 Sentiment 5
per
Penny Wan
Penny Wan, an Independent Director of Abbott Laboratories, attended the closing bell ceremony.
Importance 5 Sentiment 5
per
Sridar Iyengar
Sridar Iyengar, a former Independent Director of Abbott Laboratories, attended the closing bell ceremony.
Importance 5 Sentiment 5
NEWSDESK
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About NewsDesk

NewsDesk is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.newsdesk.dev.